Association between cardiac conduction block and cardiovascular disease and all-cause mortality: The kailuan study

Xuemei Yang1, Shuohua Chen2, Haicheng Song3

  • 1Department of Rheumatic Disease, Kailuan General Hospital, Tangshan, Hebei, China; Graduate school, North China University of Science and Technology, Tangshan, Hebei, China.

PubMed

Insights

Cardiac conduction block (CCB) significantly increases the risk of cardiovascular disease (CVD) and all-cause mortality in the general population. Early prevention strategies for CCB are crucial for reducing these adverse health outcomes.

Area of Science:

  • Cardiology
  • Public Health
  • Epidemiology

Background:

  • Bundle branch block and atrioventricular block are known risk factors for cardiovascular disease (CVD) and mortality.
  • The specific relationship between broader cardiac conduction block (CCB) and both CVD and all-cause mortality has not been extensively explored.

Purpose of the Study:

  • To investigate the association between cardiac conduction block (CCB) and the incidence of cardiovascular disease (CVD) and all-cause mortality.
  • To evaluate the impact of CCB on mortality and CVD events in a large population cohort.

Main Methods:

  • Utilized data from 145,805 participants in the Kailuan study, with a mean follow-up of 12.5 years.
  • Cardiac conduction block (CCB) was identified using 12-lead electrocardiography (ECG).
  • Mortality and CVD events were tracked through multiple comprehensive data sources.

Main Results:

  • Individuals with CCB exhibited a higher cumulative incidence of CVD (18.38% vs. 12.14%) and all-cause mortality (33.45% vs. 14.18%) compared to those without CCB.
  • Multivariable analysis revealed significantly increased hazard ratios for CCB: 1.25 for CVD and 1.31 for all-cause mortality.
  • The association between CCB and adverse outcomes was notably stronger in younger individuals compared to older participants.

Conclusions:

  • Cardiac conduction block (CCB) is an independent risk factor associated with increased cardiovascular disease (CVD) and all-cause mortality in the general population.
  • These findings underscore the importance of implementing preventive strategies targeting CCB to mitigate risks of CVD and mortality.
Abstract

Related Concept Videos

Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
31
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
1.4K
Heart Failure Drugs: β-Blockers01:22

Heart Failure Drugs: β-Blockers

β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
341
Assessment of the Cardiovascular System I: Subjective Data01:23

Assessment of the Cardiovascular System I: Subjective Data

A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
343
Imaging Studies for Cardiovascular System III: X-Ray01:20

Imaging Studies for Cardiovascular System III: X-Ray

The most common cardiovascular diagnostic test is an X-ray. It produces images of the heart, blood vessels, and adjacent structures.
Definition and Purpose
An X-ray, or radiograph, is a non-invasive method that uses ionizing radiation to take images of internal structures. It is mainly used in cardiac imaging to examine the heart, lungs, and major blood vessels, aiming to identify abnormalities in the heart's size, shape, and position, such as heart failure, congenital defects, and vascular...
188
Conduction System of the Heart01:19

Conduction System of the Heart

Autorhythmicity is a term that refers to the heart's inherent ability to generate electrical signals and instigate muscle contractions. This self-regulating conduction system within the heart consists of two key components: the pacemaker cells and specialized conducting cells.
The pacemaker cells are located in two primary nodes: the sinoatrial (SA) node and the atrioventricular (AV) node. The SA node pacemaker cells can autonomously depolarize, triggering an action potential that leads to the...
7.1K